Literature DB >> 33972155

CXCL13 shapes tertiary lymphoid structures and promotes response to immunotherapy in bladder cancer.

Mathieu Rouanne1, Nicholas Arpaia2, Aurélien Marabelle3.   

Abstract

Entities:  

Keywords:  Anti–PD-L1; Bladder cancer; CXCL13; Tertiary lymphoid structures

Year:  2021        PMID： 33972155     DOI： 10.1016/j.ejca.2021.03.054

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  2 in total

1.  Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma.

Authors:  Azaz Ahmed; Sophia Köhler; Rosa Klotz; Nathalia Giese; Thilo Hackert; Christoph Springfeld; Inka Zörnig; Dirk Jäger; Niels Halama
Journal:  Oncoimmunology       Date:  2022-01-31       Impact factor: 7.723

Review 2.  Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer.

Authors:  Ching-Hung Hsieh; Cheng-Zhe Jian; Liang-In Lin; Guan-Sian Low; Ping-Yun Ou; Chiun Hsu; Da-Liang Ou
Journal:  Cancers (Basel)       Date:  2022-01-07       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.